JK

Jayamala Kamal Kishore Kataria

Director Alternate Director DIN 02527947
DIN 02527947 First appointment Feb 2008 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Jayamala Kamal Kishore Kataria

Data last updated:

Jayamala Kamal Kishore Kataria was an Alternate Director at Remedia Therapeutics Private Limited (2008–2013) and Director at Donawita Healthcare India Private Limited (from 2009). The companies operate in Chemicals.

DIN 02527947
Primary Designation Alternate Director
Industry Chemicals
First Appointment 25 Feb 2008
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Remedia Therapeutics Private Limited U24110GA2008FTC005585
Alternate Director25 Feb 20082008Strike Off
Director13 Jul 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Donawita Healthcare India Private Limited
Remedia Therapeutics Private Limited
Premium access

Shareholding and investment profile for Jayamala Kamal Kishore Kataria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayamala Kamal Kishore Kataria

Jayamala Kamal Kishore Kataria was first appointed on 25 Feb 2008 as Alternate Director at Remedia Therapeutics Private Limited. The most recent appointment on record is 13 Jul 2009 at Donawita Healthcare India Private Limited.

Jayamala Kamal Kishore Kataria held 2 earlier board appointments: Remedia Therapeutics Private Limited (Alternate Director, 25 Feb 2008 to 15 Jul 2013); Donawita Healthcare India Private Limited (Director, from 13 Jul 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available